AUTL
Autolus Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.71 / 10
Netural
Fund-flow analysis reveals robust dynamics with a score of 7.31/10; overall, block, and extra-large inflows are positive, though small, medium, and large movements are mixed. Analyst sentiment is overwhelmingly bullish (Strong Buy), supporting the positive fund-flow reading.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-12
InstitutionNeedham
Times predicted8
Historical Win Rate37.5%
What is the analyst consensus for AUTL?
- AUTL holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.71/10 (Netural).
